XBiotech (XBIT) Liabilities and Shareholders Equity (2014 - 2026)
XBiotech (XBIT) reported Liabilities and Shareholders Equity of $133.65 million for Q2 2026, down 25.2% from $178.68 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, XBiotech posted Liabilities and Shareholders Equity of $150.08 million, down 24.6% from FY2024.
- Liabilities and Shareholders Equity has declined for six consecutive years, with a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $199.09 million in FY2024 (-12.1%), $226.62 million in FY2023 (-7.9%), $246.1 million in FY2022 (-10.6%) and $275.18 million in FY2021 (-22.2%).
- The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q3 2019.
- Over the past five years, the year-over-year decline in Liabilities and Shareholders Equity ranged from 5.9% (Q1 2024) to 25.2% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | XBiotech | 66.77 Mn | 66.77 Mn | - | 133.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133.65 Mn |
| Dec 31, 2025 | 150.08 Mn |
| Sep 30, 2025 | 172.42 Mn |
| Jun 30, 2025 | 178.68 Mn |
| Mar 31, 2025 | 181.86 Mn |
| Dec 31, 2024 | 199.09 Mn |
| Sep 30, 2024 | 209.85 Mn |
| Jun 30, 2024 | 215.56 Mn |
| Mar 31, 2024 | 227.86 Mn |
| Dec 31, 2023 | 226.62 Mn |
| Sep 30, 2023 | 229.60 Mn |
| Jun 30, 2023 | 235.14 Mn |
| Mar 31, 2023 | 242.12 Mn |
| Dec 31, 2022 | 246.10 Mn |
| Sep 30, 2022 | 250.83 Mn |
| Jun 30, 2022 | 266.46 Mn |
| Mar 31, 2022 | 270.80 Mn |
| Dec 31, 2021 | 275.18 Mn |
| Sep 30, 2021 | 279.52 Mn |
| Jun 30, 2021 | 353.96 Mn |
API Access
XBiotech Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();